According to IMARC Group’s latest report, titled “Europe Transfection Technologies Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the Europe transfection technologies market is expected to exhibit strong growth during 2021-2026. Transfection represents the process of introducing foreign nucleic acids, including oligonucleotides, Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA), etc., into the eukaryotic cells via nonviral procedures. It is performed by utilizing chemical, physical, and biological methods for modifying particular properties of the cell. Moreover, transfection technologies are used for various genomic studies, including in vitro research, RNA interference, cell representation, etc. Besides this, it is also applied in the bio-production of proteins and vaccines. As a result, transfection technologies find extensive usage in target validation, drug discovery, cellular research, etc.
Request for a PDF sample of this report: https://www.imarcgroup.com/europe-transfection-technologies-market/requestsample
The increasing prevalence of several chronic diseases, such as cancer and cardiovascular ailments, is primarily strengthening the Europe transfection technologies market. Besides this, the elevating focus on developing protein therapeutics, along with the rising collaborations among leading research institutes for drug discovery projects, is also acting as another significant growth-inducing factor. Additionally, both pharmaceutical and biotech companies are increasingly investing in (R&D) activities, thereby bolstering the market growth in the region. Furthermore, the growing integration of advanced technologies is also enabling researchers to monitor the function of a particular gene or product by enhancing or hindering its expression. Apart from this, improving recombinant proteomics and technologies are further projected to drive the transfection technologies market growth in Europe over the forecasted period. Looking forward, IMARC Group expects the global market to continue its robust growth during the forecast period (2021-2026).
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Breakup by Product Type:
Breakup by Application:
- Therapeutic Delivery
- Bio-Medical Research
- Protein Production
Breakup by Transfection Method:
- Cationic Lipid Transfection
- In-Vivo Transfection
Breakup by Technology:
- Physical Transfection
- Biochemical Based Transfection
- Viral-Vector Based Transfection
Breakup by End User:
- Research Centers and Academic Institutes
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
Breakup by Country:
- United Kingdom
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://bit.ly/3o0l9gb
We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Market Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800